
Muthoot Finance share price declines 5% despite stellar Q4 earnings
Muthoot Finance delivers stellar FY25 results, but stock under pressure amid broader market sentiment
Muthoot Finance, India's largest gold loan company, delivered a strong performance for the quarter as well as financial year ended March 31, 2025. Despite the strong fundamentals, its shares fell over 5 percent on Thursday, May 15, amid overall weak market sentiment.
For the March quarter (Q4FY25), the Kerala-headquartered firm reported a 22 percent year-on-year increase in consolidated net profit at ₹ 1,444 crore, up from ₹ 1,182 crore in the same quarter last year. This surge was supported by robust growth in its lending portfolio. On a standalone basis, net profit stood at ₹ 1,479 crore, marking a 41 percent rise compared to ₹ 1,050 crore in the year-ago quarter.
The company's consolidated assets under management (AUM) jumped 37 percent year-on-year to ₹ 1.22 lakh crore, while standalone AUM surged 41 percent to ₹ 1.06 lakh crore. Muthoot's gold loan portfolio continued to be its main growth driver, with gold loan AUM reaching an all-time high of ₹ 1,02,956 crore—a 41 percent jump over the previous year.
Annual consolidated profit after tax for FY25 stood at ₹ 5,352 crore, up 20 percent from ₹ 4,468 crore last year. Standalone profit also saw a sharp 28 percent rise to ₹ 5,201 crore. The company reported its highest-ever interest income of ₹ 15,586 crore for the year, reflecting strong customer repayment trends and an expanding lending base.
In terms of operational metrics, Muthoot Finance achieved multiple milestones. The average gold loan AUM per branch touched a new high of ₹ 21.21 crore. The company disbursed ₹ 21,888 crore in gold loans to nearly 18 lakh new customers during the year—both the highest-ever figures in its history. The total gold pledged as security in Muthoot's lockers reached 208 tonnes.
To reward shareholders, Muthoot Finance declared its highest-ever dividend of 260 percent, translating to ₹ 26 per equity share of face value ₹ 10 each.
However, performance from its subsidiaries presented a mixed picture. The group's microfinance arm, Belstar Microfinance, reported a 20 percent decline in AUM to ₹ 7,980 crore, down from ₹ 10,023 crore in the previous year. The subsidiary also saw its annual net profit shrink sharply to ₹ 46 crore from ₹ 340 crore amid industry-wide stress and asset quality concerns.
Despite the exceptional earnings report, Muthoot Finance shares dropped as much as 5.1 percent to ₹ 2,139.20 on the BSE. The stock remains over 12 percent below its 52-week high of ₹ 2,444.65 touched in March 2025. It has gained 35 percent from its 52-week low of ₹ 1,580 hit in June 2024.
On a yearly basis, the stock is still up over 34 percent. But it has struggled in recent months—down around 1 percent so far in May after a 9 percent correction in April. This follows a 12 percent rally in March, a 5.5 percent decline in February, and a 5.7 percent gain in January.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
21 minutes ago
- Hindustan Times
Is stock market closed or open tomorrow (June 6)? Check holiday list
As traders and investors prepare for the upcoming sessions, there is some uncertainty regarding whether the stock markets will observe a holiday on Friday in observance of Eid-ul-Adha (Bakrid). According to the Stock market calendar holiday on the official websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), there is no holiday June 6, 2025. There is no holiday scheduled for the month of July for the stock market according to BSE and NSE. 15 August, 2025- Independence Day (Friday) 27 August, 2025- Ganesh Chaturthi (Wednesdaay) 02 October, 2025- Mahatma Gandhi (Thursday) Jayanti/Dussehra 21 October, 2025- Diwali Laxmi Pujan (Tuesday) 22 October, 2025- Diwali Balipratipada (Wednesday) 05 November, 2025- Prakash Gurpurb Sri Guru Nanak Dev (Wednesday) 25 December, 2025- Christmas (Thursday) Also read: Bank holiday: Are banks across India open or closed tomorrow, June 6? Other than this, Muhurat Trading will be conducted on Tuesday, October 21, 2025. Overall there are a total of 14 holidays marked for this year. Before this, there was a scheduled stock market holiday on May 1 due to the celebration of Maharashtra Day. Eid ul-Adha will be celebrated on June 7, Saturday, marking it as a day of sacrifice and devotion to Allah. This day is a reminder of the sacrifice of Prophet Ibrahim who was asked by Allah to sacrifice his son as an act of devotion towards God. On this occasion banks across several states will remain closed on Saturday according to RBI. The past stock market holidays included Maharashtra Day on 1 May, Dr. Babasaheb Ambedkar Jayanti on April 10, Id-ul-Fitr on March 31 and Holi on March 14, 2025.


Mint
34 minutes ago
- Mint
Power Grid Corporation share price edges higher after acquiring PFC subsidiary. Details here
Power Grid Corporation's share price rose over 2 per cent in intraday trade on the BSE on Thursday, June 5, after it acquired MEL Power Transmission Limited—a wholly-owned subsidiary of PFC Consulting Limited, itself a subsidiary of Power Finance Corporation (PFC). Power Grid share price opened at ₹ 290.05 against its previous close of ₹ 288.60 and climbed 2.30 per cent to an intraday high of ₹ 295.25. Meanwhile, PFC share price also climbed nearly 2 per cent during the session. In an exchange filing on June 5, PFC said: "MEL Power Transmission Limited, wholly-owned subsidiary of PFC Consulting Limited (a wholly-owned subsidiary of Power Finance Corporation Limited) has been transferred to Power Grid Corporation of India Limited, the successful bidder on 4th June, 2025." (This is a developing story. Please check back for fresh updates.)
&w=3840&q=100)

Business Standard
an hour ago
- Business Standard
Dr Reddy's, Alvotech join hands to develop biosimilar for cancer treatment
Dr Reddy's Laboratories on Thursday said it has joined hands with global biotech firm Alvotech to co-develop and commercialise a biosimilar product for treating multiple types of cancer. The Hyderabad-based drug major has entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets, Dr Reddy's Laboratories said in a statement. Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were USD 29.5 billion. The collaboration combines Dr Reddy's and Alvotech's proven capabilities in biosimilars thereby speeding up the development process and extending the global reach for this biosimilar candidate, the company noted. "It further enables us to increase the availability of cost-effective, critical biologic medications to patients world-wide," he added. Dr Reddy's shares were trading 3.49 per cent up at Rs 1,295.80 apiece on BSE.